Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19

Cell Reports(2022)10.1016/j.celrep.2022.111020Source: DataRank Database

Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19 is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.74)OA: goldTopics (31)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Syed A. Rahman ORCID,Anthony R. Cillo ORCID,Godhev Manakkat Vijay,Ashwin Somasundaram ORCID,Creg J. Workman ORCID

Live enrichment

PubMed:35738278 OpenAlex:https://openalex.org/W4282589446

National Institutes of Health

Grant: U01AI141990

NIAID

Grant: DP2AI164325

National Institutes of Health

Grant: 2U01AI141990-06

Programming Durable Immune Responses To Vaccination

National Institutes of Health

Grant: 5DP2AI164325-04

Using three-dimensional protein networks to uncover immuno-modulatory molecular phenotypes in infectious disease

FWCI

1.74

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: CC BY NC ND

journalhttp://www.cell.com/article/S2211124722008099/pdf

publisherhttp://www.cell.com/article/S2211124722008099/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124722008099?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124722008099?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2022.111020

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0301 basic medicine03 medical and health sciences

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralHumansPandemicsSpike Glycoprotein, Coronavirus

Keywords

AntigenCoronavirusBiologyAntibodyVirologyCoronavirus disease 2019 (COVID-19)PandemicImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseMedicineInfectious disease (medical specialty)Internal medicineSARS-CoV-2ReportSpike Glycoprotein, CoronavirusCOVID-19HumansAntibodies, ViralPandemics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Reduced inequalities